• Markets
• News
• Learn

Shares of Ovid Therapeutics Inc (NASDAQ:OVID) dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed its primary endpoint.

Takeda Pharmaceutical Co Ltd (NYSE:TAK) announced topline data from its SKYLINE and SKYWAY Phase 3 studies of Soticlestat (TAK-935) for the treatment of Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS).

AMMO shares dipped 19.1% to $2.0306 on Friday.

Here are some other stocks moving in today’s mid-day session.

Gainers

• Interactive Strength Inc. (NASDAQ:TRNR) shares climbed 148% to $7.07 after dipping 19% on Friday.
• Mustang Bio, Inc. (NASDAQ:MBIO) shares jumped 145% to $0.32 after the company announced safety and efficacy data from the complete Waldenstrom Macroglobulinemia cohort of its Phase 1/2 clinical trial of MB-106, showing an overall response rate of 90% with one patient remaining in complete remission at 31 months.
• Allego N.V. (NASDAQ:ALLG) gained 126.4% to $1.6750 after the company and its majority shareholder, Meridiam, announced a transaction framework agreement under which Meridiam will launch a tender offer for all issued and outstanding Allego shares not owned by Meridiam, with the option to tender shares for $1.70 per share in cash.
• Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) shares gained 92.6% to $6.74 after surging 24% on Friday. Scinai Immunotherapeutics, last week, received a non-binding Letter of Intent from the European Investment Bank for converting loan into equity.
• TRxADE HEALTH, Inc. (NASDAQ:MEDS) rose 47% to $9.50.
• The Aaron’s Company, Inc. (NYSE:AAN) gained 32.2% to $9.97 after the company announced that it entered into a definitive agreement to be acquired by IQVentures Holdings.
• AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) jumped 27% to $0.1044 after the company announced a $1 million share repurchase program.
• Xponential Fitness, Inc. (NYSE:XPOF) surged 21.3% to $13.68. Xponential Fitness announced the appointment of Mark King as Chief Executive Officer.
• Silynxcom Ltd. (NASDAQ:SYNX) gained 21.8% to $3.14.
• Venus Concept Inc. (NASDAQ:VERO) gained 13.6% to $1.0650 after the company announced that it has entered a new strategic resurfacing and skin tightening device supply arrangement with Skin Laundry Holdings.
• Envirotech Vehicles, Inc. (NASDAQ:EVTV) rose 12.8% to $1.4899.
• CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) gained 12.8% to $3.1459. CNS Pharmaceuticals recently announced pricing of registered direct offering and concurrent private placement.
• ENDRA Life Sciences Inc. (NASDAQ:NDRA) gained 11.8% to $0.1159 after a 13G filing showed a 9.99% passive stake from S.H.N. Financial Investments Ltd.
• Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) climbed 10.5% to $2.0099. HC Wainwright & Co. analyst Joseph Pantginis initiated coverage on Lexicon Pharmaceuticals with a Buy rating and announced a price target of $10.
• XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) shares climbed 10.5% to $2.31 after falling around 5% on Friday. XTL recently entered into definitive agreement to acquire The Social Proxy.
• Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) gained 10.2% to $28.58. Mirum’s Volixibat achieved interim analyses in VANTAGE PBC and VISTAS PSC studies.
• Ouster, Inc. (NYSE:OUST) shares rose 8.5% to $11.21. Ouster Director Virginia Boulet bought a total of 10,000 shares at an average price of $10.30.
• Primo Water Corporation (NASDAQ:PRMW) gained 7.8% to $24.08 after the company and BlueTriton agreed to merge.

Losers

• Aerovate Therapeutics, Inc. (NASDAQ:AVTE) shares dipped 90.8% to $2.26 after the company reported 24-week topline results from phase 2b portion of IMPAHCT evaluating AV-101 for pulmonary arterial hypertension.
• Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) shares dipped 33% to $3.9950. Kaival Brands Innovations Group shares jumped 338% on Friday after the company announced a $5 million offering of 3,012,048 units at $1.66 per unit.
• Bluejay Diagnostics, Inc. (NASDAQ:BJDX) fell 29.4% to $0.36 in pre-market trading after jumping 12% on Friday.
• Workhorse Group Inc. (NASDAQ:WKHS) declined 26% to $2.22. Workhorse announced a 1-for-20 reverse stock split of its common stock last week after shareholders approved the move at the company's annual meeting of stockholders in May.
• AMC Networks Inc. (NASDAQ:AMCX) fell 25.7% to $11.67 after the company announced a private offering of $125 million of convertible senior notes.
• iPower Inc. (NYSE:IPW) shares fell 24.4% to $2.49 after the company announced a $5 million registered direct offering.
• Scorpius Holdings, Inc. (NASDAQ:SCPX) fell 21.3% to $0.0763 after the company received NYSE American notice of delisting and reported plans to appeal.
• Atara Biotherapeutics, Inc. (NASDAQ:ATRA) declined 20.8% to $0.4044. Atara Biotherapeutics announced a 1-for-25 reverse stock split.
• 22nd Century Group, Inc. (NASDAQ:XXII) dipped 20.7% to $0.6405.
• SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) fell 20.6% to $1.19. SELLAS Life Sciences announced review of ongoing Phase 3 REGAL clinical trial of Galinpepimut-S in acute myeloid leukemia by IDMC.
• Virgin Galactic Holdings, Inc. (NYSE:SPCE) dipped 19.6% to $11.00.
• Feutune Light Acquisition Corporation (NASDAQ:FLFV) shares fell 18.5% to $7.99.
• MYT Netherlands Parent B.V. (NASDAQ:MYTE) declined 13.1% to $4.31.
• Biomea Fusion, Inc. (NASDAQ:BMEA) fell 12.8% to $4.9190.
• BIMI Holdings Inc. (NASDAQ:BIMI) shares fell 12.6% to $1.92 after gaining 23% on Friday.
• Cemtrex, Inc. (NASDAQ:CETX) fell 12.2% to $0.2451.
• La Rosa Holdings Corp. (NASDAQ:LRHC) shares declined 11.1% to $1.04. La Rosa Holdings shares jumped around 76% on Friday after the company filed a request for the withdrawal of its registration statement on a Form S-1.
• Evotec SE (NYSE:EVO) shares declined 10.5% to $4.07.
• ZKH Group Limited (NYSE:ZKH) fell 10.2% to $3.5850. ZKH Group recently announced a $50 million share repurchase program.
• Bitdeer Technologies Group (NASDAQ:BTDR) declined 9% to $9.05.
• FuelCell Energy, Inc. (NASDAQ:FCEL) fell 6.8% to $0.7636.
• Louisiana-Pacific Corporation (NYSE:LPX) declined 6.3% to $86.25 after Goldman Sachs downgraded the stock from Neutral to Sell and lowered its price target from $89 to $81.
• Coeur Mining, Inc. (NYSE:CDE) fell 5.3% to $5.44.

Now Read This: Wall Street’s Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields